WO2000048532A1 - Hair used as a biologic disk, replacement, and/or structure and method - Google Patents
Hair used as a biologic disk, replacement, and/or structure and method Download PDFInfo
- Publication number
- WO2000048532A1 WO2000048532A1 PCT/US2000/004054 US0004054W WO0048532A1 WO 2000048532 A1 WO2000048532 A1 WO 2000048532A1 US 0004054 W US0004054 W US 0004054W WO 0048532 A1 WO0048532 A1 WO 0048532A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hair
- disk
- comprised
- sack
- replacement
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/441—Joints for the spine, e.g. vertebrae, spinal discs made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/3654—Cartilage, e.g. meniscus
- A61L27/3658—Intervertebral discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2/30965—Reinforcing the prosthesis by embedding particles or fibres during moulding or dipping
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2817—Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30581—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid
- A61F2002/30583—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid filled with hardenable fluid, e.g. curable in-situ
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/444—Intervertebral or spinal discs, e.g. resilient for replacing the nucleus pulposus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2002/4495—Joints for the spine, e.g. vertebrae, spinal discs having a fabric structure, e.g. made from wires or fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0085—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof hardenable in situ, e.g. epoxy resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00023—Titanium or titanium-based alloys, e.g. Ti-Ni alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/38—Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs
Definitions
- the field of the invention relates to biologic disks, replacements, and/or structures principally for human and animal use.
- the normal human disk is made of multiple layers (13) of collagen and a highly hydrophilic mucopolysaccharide center. This is similar to a radial car tire.
- This construct converts compression axial loads on the gelatinous center to the outer collagen fibers as tensile forces. This tissue is highly viscoelastic.
- the construct provides both mobility and stability to the spinal joints.
- Unfortunately the chemical properties of the gelatinous center material (nucleus pulposis) deteriorate with age and become less hydrophilic. Forces are not converted from compression to tension as well and more compression and torsional loads are conferred to the outer layers (annulus). These layers deteriorate and lose their integrity forming multiple small tears, which coalesce and become large ones.
- T he disk loses height; material bulges or extrudes into inappropriate locations through ruptured annular walls.
- the grip on the vertebra slackens and chronic nerve stimulation occurs due to release of degenerated debris and loss of space for the nerves.
- the spinal joint is actually three joints, two facet joints and one disk.
- the three joints interact to allow the right balance of mobility and stability for spine function as we know it. Research has shown that deterioration occurs first in the disk, and then as a consequence of changes in the facet joints. Therefore, replacing the disk function will halt deterioration of the entire joint complex.
- a biologically compatible prosthesis will certainly be the future reality for disk replacement.
- Hair which is immunoiogically silent, strong, very modifiable and has the potential for biological incorporation is the answer.
- the former in one embodiment, can be constructed similarly to a textile from autologous or homologous hair.
- the latter in one embodiment, can be constructed by processing keratin sulfate or utilizing another substance such as a hydrophilic gel, poloyxymer 407, and/or regenerated in vivo by utilization of morphogenetic growth factors.
- Recombinant growth factors are being produced now and some do produce the same substances in the nucleus pulposis under appropriate conditions in vivo.
- One embodiment includes a "hair bag” inserted into the center of the human disk through a small incision and that is then filled with a gelatinous substance containing cartilage growth factors.
- the new somewhat similar "disk” forms within the deteriorated one.
- the tissue may be more fibrotic than normal, and have less elasticity than normal. This would nevertheless meet the goal of allowing motion and stability, and therefore greatly improve symptomatology.
- hair as a biologic implant, replacement, and/or structure.
- Such implants can be cosmetic implants.
- Additional blood vessel replacements can be constructed from hair.
- hair can be used for joint resurfacing or meniscal replacement.
- hair can be used as a biological endoprosthesis for ligament and tendons.
- Fig. 1 is a representation of an embodiment of the first artificial disk structure of the invention with a polymer retained in a sack. Fig. 1 is attached.
- Fig. 2 is a representation of an embodiment of the second artificial disk structure of the invention with a disk comprised of hair with the hair in the center of the artificial disk specially treated to model the complex polymer found in a natural disk. Fig. 2 is attached.
- Fig. 3 is a representation of an embodiment of a cosmetic prosthesis for a nose.
- Fig. 4 is an embodiment of a vascular graph of the invention.
- Fig. 5 is an embodiment of a joint resurfacing graph of the invention.
- Fig. 6 is an embodiment of a tendon or ligament graph of the invention.
- a state-temperature dependent polymer can be injected as a liquid into the diseased intervertebral disk, and then can undergo a change to a solid viscoelastic state at body temperature, which can have similar properties as the normal intervertebral disk.
- the polymer can include, by way example, any one of the following polymers. These polymers include Poloxamer 407 and other Poloxamers, polymer combinations, and polypropylene. These polymers can be acquired under the trade names Poloxamer 407, Plannemic-Acid F127, from the following company: Sigma Aldrich.
- a woven outer sack 10 can be used to reproduce the normal disks function.
- This sack 10 would need to be biocompatible to facilitate ingrowth of normal fibrous or fibrocartiliginous tissue, anchoring and melding the artificial disk with remnants of living disk tissue and/or the vertebral bone.
- Possible candidates for this outer sheath are various polymer compounds, and the recipients own hair processed to form a tightly woven fabric. The proteins in recipient's hair will not be subject to rejection phenomena and thus, be readily accepted by the recipient's immune system, a crucial factor for ingrowth to occur.
- Polymer materials which could be used to form the outer sack include: polypropylene, polylactic acid materials, polyesther polymer mesh, composites of collagen and BMP, titanium fiber with BMP with or without non-collagenase proteins, polydioxanone, poiyphosphazenes and BMP, ceramic collagen composite, expanded polytetrafluoroethylene barrier membranes, and ethylene-vinyl acetate copolymers in methylene chloride (Elvax 40).
- polymers are characterized as having the following (physical, mechanical, chemical, biomechanical) properties and ranges of properties: good tensile strength, low coefficient of elasticity, capacity for soft tissue in growth or replacement in vivo, binding affinity for BMP, TGF-Beta, and other bone, fibrous and cartilage tissue growth factors, resistance to fracture, and biocompatability.
- This process includes one or a combination of the following: Heparin SO4 treatment, dextran, protease, elastase, collagenase, guanidine hydrochloride and lithium bromide exposure.
- the hair would be woven or blended together using one of the following techniques. These techniques include: denaturation, acid treatment, loom and machine weaving.
- the sack can be inserted in the inter-discal space.
- the disk material can be removed using a number to techniques currently on the market.
- the sack 10 can, by way of example only, be inserted through a cannula in a minimally invasive technique in order to position the sack in the space between two adjacent vertebral bodies.
- the sack 10 can be injected and filled with the appropriate polymer 12 or other material.
- These materials can be state-dependant such that at one temperature, which is different than that of the body temperature of the patient, the materials flow more easily through a needle or cannula, and at about body temperature the materials become more able to support the weight along the spinal column. Thus the materials can become more viscous and resilient once attaining the temperature of the body of the patient.
- the sack is comprised of woven hair which is then filled with a polymer.
- a disk replacement 20 is made of processed hair entirely.
- the process for processing the hair is as follows. This process includes one or more of the following: steps of denaturation, collagenase, protease, heparin sulphate, and dextran exposure.
- the hair can then be woven together in a mass and inserted into the disk space using a variety of techniques including from open surgery to insertion through an appropriately sized cannula.
- the hair can be a matrix structure characterized and described as follows.
- the matrix structure can include a denaturation, reduction of disulfide bonds (cyanogen bromide) proteolysis.
- Bone Morphogenic Protein can include the following types BMP's 1-15, TGF-Beta, insulinlike growth factor, platelet derived growth factor. Additionally, the complex organic polymer which makes up much of the center of the normal disk and is responsible for its properties can be chemically created from hair and processed collagen to use as the central matrix of the artificial disk.
- a process for treating the hair based collagen matrix, in order to create the central nucleus of the artificial disk is as follows.
- This method includes one or more of the following steps of heparin sulphate or other polyanionic compound denaturation, and guanidine hydrochloride exposure.
- An outer woven hair bag would still be used in this case to confer the necessary biomechanical properties.
- This hair bag or sack can be constructed and have the properties of the sack previously described above.
- the basic disk implant is comprised of multiple layers 22, 24, 26 of woven hair with each layer having a different orientation.
- the chemical processing of hair to modify its structure for use as (i) a Morphogenic protein carrier, and to (ii) increase its flexibility so it can be used as a strong "net * for use as a annulus replacement is as follows: This process includes mechanical weaving, partial denaturation, heparin treatment, collagenase and proteolytic treatment. BMP (a cartilage and bone growth factor), in a particular embodiment can be carried by a product known as Poloxamer 407. The characteristics of this material are found in Table 1 below.
- PluracareF 127 surfactant is a block 547427 copolymer of ethylene glycol and propyiene glycols
- Pluracare F 127 is used as a solubilizer and emulsifier in a wide variety of areas from cosmetics to oral care products. At concentrations of about 20% in water it forms stable, clear, ringing gels in which a wide variety of ingredients can be incorporated. It is also used as a solubilizer.
- HLB is in the range of 18 to 23.
- Table 2 demonstrates a method that has successfully caused BMP to be injected into animal subjects and create cartilage and bone growth. Specific results of this example include formation of a mature ossicle of bone with bone marrow cells in the middle of the injection site. The response was dose related.
- animal hair can be a carrier for BMP.
- Poloxamer 407 and similar compounds can be a carrier for BMP.
- Further Poloxamer 407 and similar compounds can be used as a BMP carrier in conjunction with the use of hair to make an artificial disk.
- the BMP in such an arrangement would create bone and cartilage on the outer periphery of the artificial disk in order to assist the artificial disk to bond with the upper and lower vertebral bodies which border the disk space. Additionally the BMP can assist the artificial disk to form an artificial nucleus.
- 407 and like compounds can be used as a film, a gel, or a fluid in order to prevent post surgical adhesions.
- This material is prepared as follows in a preferred embodiment in order to be positioned adjacent to a surgical site and be effective an anti-adhesion material.
- the method for preparing this compound is as follows: 25% gel of Poloxamer 407 prepared by weighing 25 grams of poloxamer crystal in a beaker and adding distilled H 2 O in a cold room at less than 3°C to bring the weight to 100 grams. Magnetic stirrer is used until a homogenous liquid is obtained. This will form a gel at room temperature.
- BMP which can be used with the present invention
- Examples of BMP which can be used with the present invention can be obtained from a review of US Patent Nos. 4,563,489; 4,857,456; 4,795,804; all of which are incorporated herein by reference.
- Other examples for the promotion of bone growth can be found in the following US Patents all of which are incorporated herein by reference: U.S. Patent Nos. 5,531 ,791 and 5,484,601.
- polylactic acid can be used as a BMP carrier for the above disk replacement embodiments, as well as Gelfoam ® , collagen, polyesther polymer mesh, composites of collagen and BMP, titanium fiber with BMP with or without non-collagenase proteins, polydioxanone, pol ⁇ phosphazenes and BMP, ceramic collagen composite, expanded polytetrafluoroethylene barrier membranes, ethylene-vinyl acetate copolymers in methylene chloride (Elvax 40), composites of human fibrin, BMP/NCP in a polymethacrylate delivery system, sintered biodegradable b-tricalcium phosphate, composites of BMP and synthetic hydroxdyapatite mesh, hydroxy apatite adsorbed BMP, calcium sulphate, poiylactic acid polymer composites, composites of poly-D (lactide coglycolide, and composites of e- caprolactone, high molecular weight poiylactic acid homopoly
- Xenograft, homologous or autologous hair is an ideal cosmetic endoprosthesis 32 for breast, lip, muscle, nose 30, buttock, eyes chest.calves and thighs.
- the strength, immunologic compatibility, and modifiable characteristics of hair and keratin sulfate make it ideal as an adjunct to plastic surgery.
- Current implants are associated with stiffening and capsule formation after implantation resulting in less than natural cosmetic results. Extensive debate regarding autoimmune disorders as a result of silicone implants would be obviated since the recipients own hair protein is recognized by the their bodies own immune system.
- Various gels can be manufactured from hair protein, which have similarity in physical characteristics to connective tissue fat and hydrophilic gels. The tensile strength of hair fibers can be used for maintenance of structural integrity to match body contours.
- various treatments are available to modify hair in order to obtain desirable structural characteristics. These include heparin sulfate, hydrolysis, lithium bromide, hydroxylation, sulfating, alkalinization and acidification. Impregnation with morphogenetic growth factors can also be utilized.
- Autologous, homologous or xenograft hair is an ideal vascular graft 40 for arterial or venous replacement. It has the strength, compliance, immunological compatibility, flexibility, and ease of weaving into the appropriate structure. Autologous or allograft implants have minimal immunologic reactivity. The appropriate porosity of woven hair allows real endothelial growth. Hair can be woven or structured to have the compliance that is not present in the other grafts and can approximate normal vascular walls. The hair implant can be easily sutured to adjacent structures, because of the above characteristics. Patency of the hair vascular graft can be maintained. Hair can also be a part of the composite graft.
- Autologous, allograft or xenograft hair is an appropriate implant for joint resurfacing and replacement for a meniscus.
- Hair can be woven and shaped into a different shape, size and porosity to fit human joints. It is immunologically compatible. It allows ingrowth of native cells into a woven structure.
- a hair graft 50 can easily be sutured to adjacent structures. It absorbs shock and stress well. Hair can be treated to form an elastomer. Hair can be fashioned into appropriate joint surfaces with reduced friction when compared to synthetic grafts. Hair as a Biological Endoprosthesis for Ligaments and Tendons
- Autologous, homologous (allograft) or xenograft hair is an appropriate tendon or ligament graft 60. Hair can be woven into strong structures. It remains flexible. The hair graft can be easily sutured to adjacent structures. The porosity of woven hair allows ingrowth of native tissues. The immunological compatibility, strength, flexibility and modifiable characteristics of hair are ideal for ligament and tendon replacement.
- the present invention can be used as a biologic disk, replacement, and/or structure.
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU29999/00A AU2999900A (en) | 1999-02-18 | 2000-02-16 | Hair used as a biologic disk, replacement, and/or structure and method |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12048699P | 1999-02-18 | 1999-02-18 | |
US60/120,486 | 1999-02-18 | ||
US16322499P | 1999-11-03 | 1999-11-03 | |
US60/163,224 | 1999-11-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000048532A1 true WO2000048532A1 (en) | 2000-08-24 |
Family
ID=26818418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/004054 WO2000048532A1 (en) | 1999-02-18 | 2000-02-17 | Hair used as a biologic disk, replacement, and/or structure and method |
Country Status (3)
Country | Link |
---|---|
US (1) | US6746485B1 (en) |
AU (1) | AU2999900A (en) |
WO (1) | WO2000048532A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1383444A2 (en) * | 2001-03-22 | 2004-01-28 | Keraplast Technologies Ltd. | Implantable prosthetic or tissue expanding device |
FR2929502A1 (en) * | 2008-04-04 | 2009-10-09 | Clariance Soc Par Actions Simp | NUCLEIC IMPLANT. |
Families Citing this family (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096375A (en) * | 1993-12-21 | 2000-08-01 | 3M Innovative Properties Company | Optical polarizer |
US6068630A (en) | 1997-01-02 | 2000-05-30 | St. Francis Medical Technologies, Inc. | Spine distraction implant |
US7959652B2 (en) | 2005-04-18 | 2011-06-14 | Kyphon Sarl | Interspinous process implant having deployable wings and method of implantation |
US5836948A (en) * | 1997-01-02 | 1998-11-17 | Saint Francis Medical Technologies, Llc | Spine distraction implant and method |
US7306628B2 (en) | 2002-10-29 | 2007-12-11 | St. Francis Medical Technologies | Interspinous process apparatus and method with a selectably expandable spacer |
CA2594492A1 (en) | 1999-03-07 | 2000-09-14 | Active Implants Corporation | Method and apparatus for computerized surgery |
US7435260B2 (en) * | 1999-08-13 | 2008-10-14 | Ferree Bret A | Use of morphogenetic proteins to treat human disc disease |
US6371984B1 (en) * | 1999-09-13 | 2002-04-16 | Keraplast Technologies, Ltd. | Implantable prosthetic or tissue expanding device |
US20030004574A1 (en) * | 1999-10-08 | 2003-01-02 | Ferree Bret A. | Disc and annulus augmentation using biologic tissue |
US6740093B2 (en) | 2000-02-28 | 2004-05-25 | Stephen Hochschuler | Method and apparatus for treating a vertebral body |
US7909853B2 (en) | 2004-09-23 | 2011-03-22 | Kyphon Sarl | Interspinous process implant including a binder and method of implantation |
US7749252B2 (en) | 2005-03-21 | 2010-07-06 | Kyphon Sarl | Interspinous process implant having deployable wing and method of implantation |
US8070778B2 (en) | 2003-05-22 | 2011-12-06 | Kyphon Sarl | Interspinous process implant with slide-in distraction piece and method of implantation |
US8048117B2 (en) | 2003-05-22 | 2011-11-01 | Kyphon Sarl | Interspinous process implant and method of implantation |
US7549999B2 (en) | 2003-05-22 | 2009-06-23 | Kyphon Sarl | Interspinous process distraction implant and method of implantation |
NZ539779A (en) * | 2002-11-05 | 2009-01-31 | Spineology Inc | A semi-biological intervertebral disc replacement system created by inserting tissue promoting material into a cavity in the disc |
US7335203B2 (en) * | 2003-02-12 | 2008-02-26 | Kyphon Inc. | System and method for immobilizing adjacent spinous processes |
US7153325B2 (en) * | 2003-08-01 | 2006-12-26 | Ultra-Kinetics, Inc. | Prosthetic intervertebral disc and methods for using the same |
US20050113923A1 (en) * | 2003-10-03 | 2005-05-26 | David Acker | Prosthetic spinal disc nucleus |
US8945223B2 (en) * | 2004-03-12 | 2015-02-03 | Warsaw Orthopedic, Inc. | In-situ formable nucleus pulposus implant with water absorption and swelling capability |
JP2007530120A (en) * | 2004-03-26 | 2007-11-01 | ヌヴァシヴ インコーポレイテッド | Porous implant for spinal disc nucleus pulposus replacement |
JP4563449B2 (en) * | 2004-03-26 | 2010-10-13 | ヌヴァシヴ インコーポレイテッド | Artificial spinal disc |
CA2574277A1 (en) * | 2004-08-09 | 2006-02-23 | Innovative Spinal Technologies, Inc. | System and method for dynamic skeletal stabilization |
US7854752B2 (en) | 2004-08-09 | 2010-12-21 | Theken Spine, Llc | System and method for dynamic skeletal stabilization |
US8012209B2 (en) | 2004-09-23 | 2011-09-06 | Kyphon Sarl | Interspinous process implant including a binder, binder aligner and method of implantation |
US8945183B2 (en) | 2004-10-20 | 2015-02-03 | Vertiflex, Inc. | Interspinous process spacer instrument system with deployment indicator |
US8409282B2 (en) | 2004-10-20 | 2013-04-02 | Vertiflex, Inc. | Systems and methods for posterior dynamic stabilization of the spine |
US8123807B2 (en) | 2004-10-20 | 2012-02-28 | Vertiflex, Inc. | Systems and methods for posterior dynamic stabilization of the spine |
US8277488B2 (en) | 2004-10-20 | 2012-10-02 | Vertiflex, Inc. | Interspinous spacer |
US8123782B2 (en) | 2004-10-20 | 2012-02-28 | Vertiflex, Inc. | Interspinous spacer |
US9161783B2 (en) | 2004-10-20 | 2015-10-20 | Vertiflex, Inc. | Interspinous spacer |
US8425559B2 (en) | 2004-10-20 | 2013-04-23 | Vertiflex, Inc. | Systems and methods for posterior dynamic stabilization of the spine |
US9119680B2 (en) | 2004-10-20 | 2015-09-01 | Vertiflex, Inc. | Interspinous spacer |
WO2009009049A2 (en) | 2004-10-20 | 2009-01-15 | Vertiflex, Inc. | Interspinous spacer |
US8613747B2 (en) | 2004-10-20 | 2013-12-24 | Vertiflex, Inc. | Spacer insertion instrument |
US8317864B2 (en) | 2004-10-20 | 2012-11-27 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for posterior dynamic stabilization of the spine |
US8128662B2 (en) | 2004-10-20 | 2012-03-06 | Vertiflex, Inc. | Minimally invasive tooling for delivery of interspinous spacer |
US9023084B2 (en) | 2004-10-20 | 2015-05-05 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for stabilizing the motion or adjusting the position of the spine |
US8012207B2 (en) * | 2004-10-20 | 2011-09-06 | Vertiflex, Inc. | Systems and methods for posterior dynamic stabilization of the spine |
US8152837B2 (en) | 2004-10-20 | 2012-04-10 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for posterior dynamic stabilization of the spine |
US8167944B2 (en) | 2004-10-20 | 2012-05-01 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for posterior dynamic stabilization of the spine |
US7763074B2 (en) | 2004-10-20 | 2010-07-27 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for posterior dynamic stabilization of the spine |
US8241330B2 (en) | 2007-01-11 | 2012-08-14 | Lanx, Inc. | Spinous process implants and associated methods |
US9055981B2 (en) | 2004-10-25 | 2015-06-16 | Lanx, Inc. | Spinal implants and methods |
CA2614133A1 (en) * | 2004-10-25 | 2006-05-04 | Lanx, Llc | Interspinous distraction devices and associated methods of insertion |
US7918875B2 (en) * | 2004-10-25 | 2011-04-05 | Lanx, Inc. | Interspinous distraction devices and associated methods of insertion |
EP2219538B1 (en) | 2004-12-06 | 2022-07-06 | Vertiflex, Inc. | Spacer insertion instrument |
US8414907B2 (en) | 2005-04-28 | 2013-04-09 | Warsaw Orthopedic, Inc. | Coatings on medical implants to guide soft tissue healing |
US9119901B2 (en) | 2005-04-28 | 2015-09-01 | Warsaw Orthopedic, Inc. | Surface treatments for promoting selective tissue attachment to medical impants |
WO2006121700A2 (en) * | 2005-05-06 | 2006-11-16 | Keraplast Technologies, Ltd. | Hydratable keratin compositions |
US20060271055A1 (en) * | 2005-05-12 | 2006-11-30 | Jeffery Thramann | Spinal stabilization |
GB0514891D0 (en) * | 2005-07-20 | 2005-08-24 | Pearsalls Ltd | Improvements in and relating to implants |
WO2006133130A2 (en) * | 2005-06-03 | 2006-12-14 | Nuvasive, Inc. | Fibrous spinal implant and method of implantation |
US7731753B2 (en) | 2005-09-01 | 2010-06-08 | Spinal Kinetics, Inc. | Prosthetic intervertebral discs |
AU2013222002B2 (en) * | 2005-09-09 | 2016-06-02 | Cytex Therapeutics, Inc. | Tissue engineering methods and compositions |
AU2006287306A1 (en) * | 2005-09-09 | 2007-03-15 | Duke University | Tissue engineering methods and compositions |
US20070083200A1 (en) * | 2005-09-23 | 2007-04-12 | Gittings Darin C | Spinal stabilization systems and methods |
US20070270952A1 (en) * | 2006-04-19 | 2007-11-22 | Spinal Kinetics, Inc. | Prosthetic intervertebral discs implantable by minimally invasive surgical techniques |
EP2062290B1 (en) * | 2006-09-07 | 2019-08-28 | Taiwan Semiconductor Manufacturing Company, Ltd. | Defect reduction using aspect ratio trapping |
US8074591B2 (en) * | 2006-09-25 | 2011-12-13 | Nuvasive, Inc. | Embroidery using soluble thread |
US9278007B2 (en) | 2006-09-26 | 2016-03-08 | Spinal Kinetics, Inc. | Prosthetic intervertebral discs having cast end plates and methods for making and using them |
US8403987B2 (en) | 2006-09-27 | 2013-03-26 | Spinal Kinetics Inc. | Prosthetic intervertebral discs having compressible core elements bounded by fiber-containing membranes |
US9381098B2 (en) * | 2006-09-28 | 2016-07-05 | Spinal Kinetics, Inc. | Tool systems for implanting prosthetic intervertebral discs |
US8845726B2 (en) | 2006-10-18 | 2014-09-30 | Vertiflex, Inc. | Dilator |
US8275594B2 (en) * | 2006-10-30 | 2012-09-25 | The Regents Of The University Of Michigan | Engineered scaffolds for intervertebral disc repair and regeneration and for articulating joint repair and regeneration |
US9265532B2 (en) | 2007-01-11 | 2016-02-23 | Lanx, Inc. | Interspinous implants and methods |
US7942104B2 (en) | 2007-01-22 | 2011-05-17 | Nuvasive, Inc. | 3-dimensional embroidery structures via tension shaping |
US7946236B2 (en) | 2007-01-31 | 2011-05-24 | Nuvasive, Inc. | Using zigzags to create three-dimensional embroidered structures |
WO2008098125A2 (en) * | 2007-02-08 | 2008-08-14 | Nuvasive, Inc. | Medical implants with pre-settled cores and related methods |
US20080255041A1 (en) * | 2007-04-11 | 2008-10-16 | Ebi, L.P. | Treatment of annulus fibrosis defects |
EP2155121B1 (en) | 2007-04-16 | 2015-06-17 | Vertiflex, Inc. | Interspinous spacer |
EP2142146A4 (en) * | 2007-05-01 | 2010-12-01 | Spinal Simplicity Llc | Interspinous implants and methods for implanting same |
US8142479B2 (en) * | 2007-05-01 | 2012-03-27 | Spinal Simplicity Llc | Interspinous process implants having deployable engagement arms |
US8282681B2 (en) * | 2007-08-13 | 2012-10-09 | Nuvasive, Inc. | Bioresorbable spinal implant and related methods |
US8591584B2 (en) * | 2007-11-19 | 2013-11-26 | Nuvasive, Inc. | Textile-based plate implant and related methods |
EP2244670B1 (en) | 2008-01-15 | 2017-09-13 | Vertiflex, Inc. | Interspinous spacer |
US8377135B1 (en) | 2008-03-31 | 2013-02-19 | Nuvasive, Inc. | Textile-based surgical implant and related methods |
US9757164B2 (en) | 2013-01-07 | 2017-09-12 | Spinal Simplicity Llc | Interspinous process implant having deployable anchor blades |
US9861399B2 (en) | 2009-03-13 | 2018-01-09 | Spinal Simplicity, Llc | Interspinous process implant having a body with a removable end portion |
US8945184B2 (en) * | 2009-03-13 | 2015-02-03 | Spinal Simplicity Llc. | Interspinous process implant and fusion cage spacer |
BRPI1014864A2 (en) | 2009-03-31 | 2017-03-28 | Lanx Inc | "implantation of spinous processes and associated methods" |
US8740948B2 (en) | 2009-12-15 | 2014-06-03 | Vertiflex, Inc. | Spinal spacer for cervical and other vertebra, and associated systems and methods |
US8353964B2 (en) | 2010-11-04 | 2013-01-15 | Carpenter Clyde T | Anatomic total disc replacement |
US11812923B2 (en) | 2011-10-07 | 2023-11-14 | Alan Villavicencio | Spinal fixation device |
US20130282121A1 (en) * | 2012-03-22 | 2013-10-24 | Ann Prewett | Spinal facet augmentation implant and method |
WO2014055480A1 (en) * | 2012-10-02 | 2014-04-10 | Mccullen Seth | Implantable devices for musculoskeletal repair and regeneration |
US9675303B2 (en) | 2013-03-15 | 2017-06-13 | Vertiflex, Inc. | Visualization systems, instruments and methods of using the same in spinal decompression procedures |
AU2015256024B2 (en) | 2014-05-07 | 2020-03-05 | Vertiflex, Inc. | Spinal nerve decompression systems, dilation systems, and methods of using the same |
WO2016054463A1 (en) | 2014-10-02 | 2016-04-07 | Mccullen Seth | Anatomically designed meniscus implantable devices |
US10064736B2 (en) | 2015-06-25 | 2018-09-04 | University of Central Oklahoma | Engineered intervertebral disc (IVD) for degenerated disc disease |
WO2017147183A1 (en) | 2016-02-23 | 2017-08-31 | University of Central Oklahoma | Process to create 3d tissue scaffold using electrospun nanofiber matrix and photosensitive hydrogel |
WO2018204440A2 (en) | 2017-05-02 | 2018-11-08 | Mccullen Seth | Composite joint implant |
US11185419B2 (en) * | 2019-02-01 | 2021-11-30 | Central Michigan University | Artificial intervertebral discs |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5137533A (en) * | 1988-12-27 | 1992-08-11 | Giampapa Vincent C | Hair implantation structure |
US5634945A (en) * | 1995-03-02 | 1997-06-03 | Pernia; Luis R. | Biological filler and use of same |
US5667961A (en) * | 1987-03-26 | 1997-09-16 | Centre International De Recherches Dermatologigues Galderma (Cird Galderma) | Skin substitute |
US5800545A (en) * | 1995-06-07 | 1998-09-01 | Yamada; Shiro | Artificial hair for implantation and process for producing the same |
US5944754A (en) * | 1995-11-09 | 1999-08-31 | University Of Massachusetts | Tissue re-surfacing with hydrogel-cell compositions |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1364366A (en) | 1920-11-10 | 1921-01-04 | Hyman & Oppenheim | Hair-roll |
US2677369A (en) | 1952-03-26 | 1954-05-04 | Fred L Knowles | Apparatus for treatment of the spinal column |
US2865380A (en) | 1956-06-04 | 1958-12-23 | Mitchell Princess | Hairpieces and method of hair preparation |
US3119398A (en) | 1962-09-24 | 1964-01-28 | Patricia L Hartland | Hair structure, process of making same and method for implanting hair in scalp |
CA992255A (en) * | 1971-01-25 | 1976-07-06 | Cutter Laboratories | Prosthesis for spinal repair |
US3875595A (en) | 1974-04-15 | 1975-04-08 | Edward C Froning | Intervertebral disc prosthesis and instruments for locating same |
CA1146301A (en) | 1980-06-13 | 1983-05-17 | J. David Kuntz | Intervertebral disc prosthesis |
US4309777A (en) | 1980-11-13 | 1982-01-12 | Patil Arun A | Artificial intervertebral disc |
US4599086A (en) | 1985-06-07 | 1986-07-08 | Doty James R | Spine stabilization device and method |
US4714469A (en) | 1987-02-26 | 1987-12-22 | Pfizer Hospital Products Group, Inc. | Spinal implant |
GB8718627D0 (en) | 1987-08-06 | 1987-09-09 | Showell A W Sugicraft Ltd | Spinal implants |
US4772287A (en) | 1987-08-20 | 1988-09-20 | Cedar Surgical, Inc. | Prosthetic disc and method of implanting |
JPH01136655A (en) | 1987-11-24 | 1989-05-29 | Asahi Optical Co Ltd | Movable type pyramid spacer |
US4874389A (en) | 1987-12-07 | 1989-10-17 | Downey Ernest L | Replacement disc |
US5484437A (en) | 1988-06-13 | 1996-01-16 | Michelson; Gary K. | Apparatus and method of inserting spinal implants |
US5047055A (en) | 1990-12-21 | 1991-09-10 | Pfizer Hospital Products Group, Inc. | Hydrogel intervertebral disc nucleus |
US5390683A (en) | 1991-02-22 | 1995-02-21 | Pisharodi; Madhavan | Spinal implantation methods utilizing a middle expandable implant |
US5123926A (en) | 1991-02-22 | 1992-06-23 | Madhavan Pisharodi | Artificial spinal prosthesis |
JP3007903B2 (en) | 1991-03-29 | 2000-02-14 | 京セラ株式会社 | Artificial disc |
US5263953A (en) | 1991-12-31 | 1993-11-23 | Spine-Tech, Inc. | Apparatus and system for fusing bone joints |
US5306309A (en) | 1992-05-04 | 1994-04-26 | Calcitek, Inc. | Spinal disk implant and implantation kit |
FR2693364B1 (en) | 1992-07-07 | 1995-06-30 | Erpios Snc | INTERVERTEBRAL PROSTHESIS FOR STABILIZING ROTATORY AND FLEXIBLE-EXTENSION CONSTRAINTS. |
US5358935A (en) | 1992-11-19 | 1994-10-25 | Robert Allen Smith | Nonantigenic keratinous protein material |
JPH06178787A (en) | 1992-12-14 | 1994-06-28 | Shima Yumiko | Centrum spacer with joint, intervertebral cavity measuring device and centrum spacer pattern |
US5534028A (en) | 1993-04-20 | 1996-07-09 | Howmedica, Inc. | Hydrogel intervertebral disc nucleus with diminished lateral bulging |
FR2704745B1 (en) | 1993-05-07 | 1995-11-24 | Erpios | Device for connecting the ends of a ligament for osteosynthesis, in particular for vertebral osteosynthesis. |
BE1007549A3 (en) | 1993-09-21 | 1995-08-01 | Beckers Louis Francois Charles | Implant. |
US5443514A (en) | 1993-10-01 | 1995-08-22 | Acromed Corporation | Method for using spinal implants |
US5514180A (en) | 1994-01-14 | 1996-05-07 | Heggeness; Michael H. | Prosthetic intervertebral devices |
FR2717675B1 (en) | 1994-03-24 | 1996-05-03 | Jean Taylor | Interspinous wedge. |
US5571189A (en) | 1994-05-20 | 1996-11-05 | Kuslich; Stephen D. | Expandable fabric implant for stabilizing the spinal motion segment |
ATE203885T1 (en) | 1994-09-08 | 2001-08-15 | Stryker Technologies Corp | HYDROGEL DISC CORE |
WO1996011642A1 (en) | 1994-10-17 | 1996-04-25 | Raymedica, Inc. | Prosthetic spinal disc nucleus |
US5562736A (en) | 1994-10-17 | 1996-10-08 | Raymedica, Inc. | Method for surgical implantation of a prosthetic spinal disc nucleus |
US5674296A (en) | 1994-11-14 | 1997-10-07 | Spinal Dynamics Corporation | Human spinal disc prosthesis |
FR2728159B1 (en) | 1994-12-16 | 1997-06-27 | Tornier Sa | ELASTIC DISC PROSTHESIS |
US5766252A (en) | 1995-01-24 | 1998-06-16 | Osteonics Corp. | Interbody spinal prosthetic implant and method |
IES80150B2 (en) | 1997-04-30 | 1998-06-03 | Eskina Developments Limited | Spinal osteosynthesis device for mechanically interconnecting two adjacent vertebrae in particular lumbar vertebrae |
US6022376A (en) | 1997-06-06 | 2000-02-08 | Raymedica, Inc. | Percutaneous prosthetic spinal disc nucleus and method of manufacture |
US5888226A (en) | 1997-11-12 | 1999-03-30 | Rogozinski; Chaim | Intervertebral prosthetic disc |
FR2771282B1 (en) | 1997-11-25 | 2000-01-28 | Jean Taylor | VERTEBRAL IMPLANT SUITABLE FOR INTRODUCTION BY A POSTERIOR ROUTE IN AN INTERVERTEBRAL SPACE |
US5948432A (en) | 1997-11-26 | 1999-09-07 | Keraplast Technologies Ltd. | Keratin-based sheet material for biomedical applications and method of production |
US5932552A (en) | 1997-11-26 | 1999-08-03 | Keraplast Technologies Ltd. | Keratin-based hydrogel for biomedical applications and method of production |
FR2775183B1 (en) | 1998-02-20 | 2000-08-04 | Jean Taylor | INTER-SPINOUS PROSTHESIS |
AU5813599A (en) | 1998-09-04 | 2000-03-27 | Spinal Dynamics Corporation | Cylindrical hemi-lunar parallel array threaded disc prosthesis |
CA2342633C (en) | 1998-09-04 | 2007-11-13 | Spinal Dynamics Corporation | Peanut spectacle multi discoid thoraco-lumbar disc prosthesis |
US6416776B1 (en) * | 1999-02-18 | 2002-07-09 | St. Francis Medical Technologies, Inc. | Biological disk replacement, bone morphogenic protein (BMP) carriers, and anti-adhesion materials |
US6113639A (en) | 1999-03-23 | 2000-09-05 | Raymedica, Inc. | Trial implant and trial implant kit for evaluating an intradiscal space |
US6783546B2 (en) | 1999-09-13 | 2004-08-31 | Keraplast Technologies, Ltd. | Implantable prosthetic or tissue expanding device |
US6371984B1 (en) | 1999-09-13 | 2002-04-16 | Keraplast Technologies, Ltd. | Implantable prosthetic or tissue expanding device |
-
2000
- 2000-02-16 AU AU29999/00A patent/AU2999900A/en not_active Abandoned
- 2000-02-16 US US09/504,826 patent/US6746485B1/en not_active Expired - Lifetime
- 2000-02-17 WO PCT/US2000/004054 patent/WO2000048532A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5667961A (en) * | 1987-03-26 | 1997-09-16 | Centre International De Recherches Dermatologigues Galderma (Cird Galderma) | Skin substitute |
US5137533A (en) * | 1988-12-27 | 1992-08-11 | Giampapa Vincent C | Hair implantation structure |
US5634945A (en) * | 1995-03-02 | 1997-06-03 | Pernia; Luis R. | Biological filler and use of same |
US5800545A (en) * | 1995-06-07 | 1998-09-01 | Yamada; Shiro | Artificial hair for implantation and process for producing the same |
US5944754A (en) * | 1995-11-09 | 1999-08-31 | University Of Massachusetts | Tissue re-surfacing with hydrogel-cell compositions |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1383444A2 (en) * | 2001-03-22 | 2004-01-28 | Keraplast Technologies Ltd. | Implantable prosthetic or tissue expanding device |
EP1383444A4 (en) * | 2001-03-22 | 2008-02-13 | Keraplast Tech Ltd | Implantable prosthetic or tissue expanding device |
FR2929502A1 (en) * | 2008-04-04 | 2009-10-09 | Clariance Soc Par Actions Simp | NUCLEIC IMPLANT. |
US8652209B2 (en) | 2008-04-04 | 2014-02-18 | Clariance | Nuclear implant |
US8740981B2 (en) | 2008-04-04 | 2014-06-03 | Clariance | Nuclear implant |
Also Published As
Publication number | Publication date |
---|---|
AU2999900A (en) | 2000-09-04 |
US6746485B1 (en) | 2004-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6746485B1 (en) | Hair used as a biologic disk, replacement, and/or structure and method | |
US6416776B1 (en) | Biological disk replacement, bone morphogenic protein (BMP) carriers, and anti-adhesion materials | |
US4880429A (en) | Prosthetic meniscus | |
US5258043A (en) | Method for making a prosthetic intervertebral disc | |
US9320708B2 (en) | Medical implants with reservoir(s) | |
CA2082427C (en) | Prosthetic intervertebral disc | |
AU676832B2 (en) | Prosthetic ligaments | |
US8092541B2 (en) | Method of using an anti-growth matrix as a barrier for cell attachment and osteo-inductive factors | |
Bayrak et al. | Engineering musculoskeletal tissue interfaces | |
Williams | Biocompatibility: performance in the surgical reconstruction of man | |
Dharadhar et al. | Biomaterials and Its Medical Applications | |
Bhat et al. | Overview of biomaterials | |
KR100744833B1 (en) | Artificial intervertebral disc comprising disc cell and the method of tissue engineered disc regeneration using the said disc cell | |
James et al. | Innovative regenerative engineering technologies for soft tissue regeneration | |
Naderi et al. | Biomaterials and structural fat grafting | |
Taylor et al. | Strategies for Bone Grafting and Bone Tissue Engineering | |
Pappas | Allografts, Artificial Tissues, and Organs | |
Marcacci et al. | Biomimetic Materials in Regenerative Medicine: A Clinical Perspective | |
Husain et al. | Biomedical Implants and Tissues: Status and Prospects | |
Grant et al. | In-vivo usage of biomaterials: a snapshot of current activity. | |
Bhat et al. | Orthopaedic Implants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |